Extraparenchymal Neurocysticercosis in Albuquerque, New Mexico

Journal of Neuroimaging

Volumn 21, Issue 1, 2011, Pages 38-43

  Figueroa, Juan J ^a   Davis, Larry E ^a,b   Magalhaes, Alvaro ^a,b  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

Author keywords

Cysticercosis; Hydrocephalus; Meningitis; Neurocysticercosis; Taenia sollium; Ventriculitis

Indexed keywords

ALBENDAZOLE; STEROID;

ADULT; AGED; ARACHNOID CYST; ARACHNOIDITIS; ARTICLE; BRAIN CYST; BRAIN VENTRICULITIS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL ASSESSMENT; EOSINOPHILIA; FEMALE; HOSPITAL; HUMAN; HYDROCEPHALUS; LUMBAR PUNCTURE; MALE; MEDICAL SCHOOL; MENINGITIS; MIGRAINE; NEUROCYSTICERCOSIS; NEUROIMAGING; PARENCHYMA; PLEOCYTOSIS; RETROSPECTIVE STUDY; UNITED STATES;

ADULT; AGED; FEMALE; HUMANS; HYDROCEPHALUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; NEW MEXICO; PREVALENCE;

EID: 78650743134     PISSN: 10512284     EISSN: 15526569     Source Type: Journal    
DOI: 10.1111/j.1552-6569.2009.00452.x     Document Type: Article

References (17)

1. Estanol B, Corona T, Abad P. A prognostic classification of cerebral cysticercosis: Therapeutic implications. J Neurol Neurosurg Psychiatry 1986;49:1131-1134.
2. Wallin MT, Kurtzke JF. Neurocysticercosis in the United States: review of an important emerging infection. Neurology 2004;63:1559-1564.
3. Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57:177-183.
4. Magalhaes A. Doencas infecciosas do sistema nervosa central. In: Magalhaes ACdA, ed. Ressonancia Magnetica do Sistema Nervoso Central. Sao Paulo, Brazil Atheneu, 1999:101-110.
5. Escobar A, Aruffo C, Cruz-Sanchez F, et al. Neuropathologic findings in neurocysticercosis. Arch Neurobiol (Madr) 1985;48:151-156.
6. Garcia HH, Gilman RH, Horton J, et al. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru. Neurology. 1997;48:1421-1427.
7. Garcia HH, Gonzalez AE, Evans CA, et al. Taenia solium cysticercosis. Lancet. 2003;362:547-556.
8. Ong S, Talan DA, Moran GJ, et al. Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departments. Emerg Infect Dis. 2002;8:608-613.
9. Proano JV, Madrazo I, Avelar F, et al. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. N Engl J Med. 2001;345:879-885.
10. Estanol B, Kleriga E, Loyo M, et al. Mechanisms of hydrocephalus in cerebral cysticercosis: implications for therapy. Neurosurgery. 1983;13:119-123.
11. Lobato RD, Lamas E, Portillo JM, et al. Hydrocephalus in cerebral cysticercosis. Pathogenic and therapeutic considerations. J Neurosurg. 1981;55:786-793.
12. Sotelo J, Marin C. Hydrocephalus secondary to cysticercotic arachnoiditis. A long-term follow-up review of 92 cases. J Neurosurg. 1987;66:686-689.
13. Davis LE. Neurocysticercosis. In: Power C, Johnson R, eds. Emerging Neurological Infections. Boca Raton, FL Taylor & Francis Group; 2005: 261-287.
14. Kuberski T. Eosinophils in the cerebrospinal fluid. Ann Intern Med. 1979;91:70-75.
15. Loyo M, Kleriga E, Estanol B. Fourth ventricular cysticercosis. Neurosurgery. 1980;7:456-458.
16. Nash TE, Singh G, White AC, et al. Treatment of neurocysticercosis: current status and future research needs. Neurology. 2006;67:1120-1127.
17. Fleury A, Hernandez M, Avila M, et al. Detection of HP10 antigen in serum for diagnosis and follow-up of subarachnoidal and intraventricular human neurocysticercosis. J Neurol Neurosurg Psychiatry. 2007;78:970-974.